Neonatal Sepsis: Clinical Trials

16 trials for Neonatal Sepsis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 4 unknown, 2 not yet recruiting, 1 active not recruiting. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 9, Unknown 4, Not yet recruiting 2, Active not recruiting 1

Follow Neonatal Sepsis: new trials by email Literature Review of Neonatal Sepsis trials Research Report on Neonatal Sepsis

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PROMab Trial: Ampicillin With or Without Gentamicin for Term Prelabour Rupture of Membranes
Ampicillin, Ampicillin + gentamicin - Rupture of Membranes Prior to Onset of Labor
Phase 4Not yet recruitingSarawak General Hospital3202026-07-012026-05-04
Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis
Vitamin D - Neonatal Sepsis, Preterm Infants
Phase 4CompletedUniversitas Padjadjaran782025-08-022026-02-05
Azithromycin for Preventing Maternal and Neonatal Infections During Labor.
oral azithromycin, no azithromycin - Maternal and Neonatal Sepsis, Intrapartum Antibiotics
Phase 4Not yet recruitingArmed Forces Hospital, Pakistan4002025-05-012025-05-06
Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial
Intravascular Hydrocortisone (stress dosage): 1 mg/k/dose each 8 hours for 5 days, Vasoactive drug therapies - Shock, Preterm Birth Complication
Phase 4Active not recruitingCoordinación de Investigación en Salud, Mexico762025-02-012025-11-25
Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.
Piperacillin/tazobactam - Late-Onset Neonatal Sepsis
Phase 4UnknownShandong University3322023-07-312023-08-08
Single Vs Multi-strain Probiotics for Preterm Neonates
Dextrose 10%, Lactobacillus Rhamnosus GG, Bifidobacterium BB-12, Lactobacillus paracasei, L casei-431, Streptococcus thermophilus TH-4 - Necrotizing Enterocolitis of Newborn, Sepsis Newborn
Phase 4CompletedMadiha, MPhil2492023-05-152025-12-22
Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.
Individualized treatment duration strategy - Early-Onset Neonatal Sepsis, Antibiotic Side Effect
Phase 4CompletedUlrikka Nygaard4882022-04-222026-01-12
NICU Antibiotics and Outcomes Trial
Ampicillin, Gentamycin, Normal saline - Microbial Colonization, Extreme Prematurity
Phase 4CompletedMichael Morowitz3592020-08-052026-04-24
Zinc Supplementation on Very Low Birth Weight Infant
Zinc Sulfate, Placebos - Early-Onset Sepses, Neonatal, Periventricular Haemorrhage Neonatal
Phase 4UnknownFakultas Kedokteran Universitas Indonesia3642019-08-202019-08-15
Efficacy of IgM Rich Immunoglobulin With Antibiotics for Bacterial Sepsis in Very Low Birth Weight Preterm Neonates
IgM rich Immunoglobin - Neonatal SEPSIS, Very Low Birth Weight Baby
Phase 4CompletedSir Takhtasinhji General Hospital602018-01-302020-07-07
Reduction of Intravenous Antibiotics In Neonates
Amoxicillin Clavulanate, Antibiotics - Neonatal Infection, Neonatal SEPSIS
Phase 4CompletedFranciscus Gasthuis5102017-11-042021-08-24
The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis
Smoflipid ® - Sepsis Newborn
Phase 4CompletedMansoura University Children Hospital402016-02-012018-03-23
Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes
I.V cefuroxime 750 mg*3/d for 2 days, I.V ampicillin 2 gram x4/d for 2 days, P.O cefuroxime 500 mgx2/d for 5 days - Premature Rupture of Membrane
Phase 4UnknownWestern Galilee Hospital-Nahariya4002015-11-012016-12-29
Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis
Lactoferrin, Placebo (for Lactoferrin) - Neonatal Sepsis
Phase 4CompletedAin Shams University1802014-08-012016-11-09
Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'
Pentoxifylline, pentaglobin - Sepsis of the Newborn
Phase 4UnknownZekai Tahir Burak Women's Health Research and Education Hospital2042009-08-012011-03-11
Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on CD11b in Septic Neonates
rh-GCSF - Neonatal Sepsis
Phase 4CompletedAin Shams University902009-04-012011-11-28

Narrower conditions

Enterocolitis, Necrotizing (2)  ·  Fetal Membranes, Premature Rupture (2)  ·  Premature Birth (2)  ·  Bronchopulmonary Dysplasia (1)  ·  Communicable Diseases (1)  ·  Hyperglycemia (1)  ·  Infections (1)  ·  Intestinal Perforation (1)  ·  Perinatal Death (1)  ·  Preterm Premature Rupture of the Membranes (1)  ·  Pulmonary Atelectasis (1)  ·  Retinopathy of Prematurity (1)  ·  Sepsis (1)  ·  Shock (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (16)  ·  Infant, Newborn, Diseases (16)  ·  Inflammation (16)  ·  Pathologic Processes (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Systemic Inflammatory Response Syndrome (16)  ·  Infections (15)  ·  Sepsis (15)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Obstetric Labor Complications (4)  ·  Pregnancy Complications (4)  ·  Urogenital Diseases (4)  ·  Digestive System Diseases (2)  ·  Enterocolitis (2)  ·  Gastroenteritis (2)

Interventions

Ampicillin (2)  ·  Gentamicins (2)  ·  pentaglobulin (2)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Anti-Bacterial Agents (1)  ·  Azithromycin (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Lactoferrin (1)  ·  Pentoxifylline (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  SMOFlipid (1)  ·  Saline Solution (1)  ·  Vitamin D (1)  ·  Zinc Sulfate (1)

Sponsors

Ain Shams University (2)  ·  Armed Forces Hospital, Pakistan (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Fakultas Kedokteran Universitas Indonesia (1)  ·  Franciscus Gasthuis (1)  ·  Madiha, MPhil (1)  ·  Mansoura University Children Hospital (1)  ·  Michael Morowitz (1)  ·  Sarawak General Hospital (1)  ·  Shandong University (1)  ·  Sir Takhtasinhji General Hospital (1)  ·  Ulrikka Nygaard (1)  ·  Universitas Padjadjaran (1)  ·  Western Galilee Hospital-Nahariya (1)  ·  Zekai Tahir Burak Women's Health Research and Education Hospital (1)

Countries

China (1)  ·  Denmark (1)  ·  Egypt (1)  ·  India (1)  ·  Indonesia (1)  ·  Israel (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Emma Malchau Carlsen, MD, PhD (1)  ·  Fiva A Kadi, MD, Ph.D (1)  ·  Gerdien Tramper (1)  ·  Ghada I Ghad, Professor (1)  ·  Henri Azis, Master (1)  ·  Imran Masood, PhD (1)  ·  Jayendra R Gohil, MD (1)  ·  Maya Wolf, MD (1)  ·  Reni Ghrahani, MD, Ph.D (1)

Results publications

PMID 12710654, PMID 15585684, PMID 16254497, PMID 16632649, PMID 19571170, PMID 20393276, PMID 20398379, PMID 22319539, PMID 22942104, PMID 23398476, PMID 25674546, PMID 25722954, PMID 26146621, PMID 26630252, PMID 28630687, PMID 31289068, PMID 3195529, PMID 32407901, PMID 35606829, PMID 36088952, PMID 36791845, PMID 42116025, PMID 42302804

NIH funding

R01HD097578 (1)